SCHEMBL15022063

SCHEMBL15022063

C#Cc1ccc(-n2cnnc2-c2ccncc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK10 P53779 4/20 0.56
▸ MAPK9 P45984 3/20 0.56
▸ HDAC8 Q9BY41 1/20 0.44
▸ OPRD1 P41143 4/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ MAPKAPK2 P49137 1/20 0.36
▸ TUBB4A P04350 2/20 0.36
▸ TUBB P07437 2/20 0.36
▸ TUBA3C P0DPH7 2/20 0.36
▸ TUBA1B P68363 2/20 0.36
▸ TUBA4A P68366 2/20 0.36
▸ TUBB4B P68371 2/20 0.36
▸ TUBB3 Q13509 2/20 0.36
▸ TUBB2A Q13885 2/20 0.36
▸ TUBB8 Q3ZCM7 2/20 0.36
▸ TUBA3E Q6PEY2 2/20 0.36
▸ TUBA1A Q71U36 2/20 0.36
▸ TUBA1C Q9BQE3 2/20 0.36
▸ TUBB6 Q9BUF5 2/20 0.36
▸ TUBB2B Q9BVA1 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15022258 0.80 MAPK9 (0.51) MAPK10MAPK9OPRD1L3MBTL1MAPKAPK2
SCHEMBL15022265 0.80 MAPK9 (0.60) MAPK10MAPK9OPRD1L3MBTL1TUBB4A
SCHEMBL11086703 0.79 MAPK9 (0.68) MAPK10MAPK9OPRD1L3MBTL1OPRM1
SCHEMBL15022984 0.74 HDAC8 (0.46) MAPK10MAPK9HDAC8KEAP1
SCHEMBL18433027 0.74 MAPK9 (0.53) MAPK10MAPK9OPRD1L3MBTL1TUBB4A
SCHEMBL25215742 0.73 MAPK9 (0.52) MAPK10MAPK9OPRD1MAPK14
SCHEMBL3271173 0.73 OPRD1 (0.52) MAPK10MAPK9OPRD1L3MBTL1TUBB4A
SCHEMBL140223 0.70 HDAC8 (0.71) HDAC8KEAP1MAPK14
SCHEMBL15022094 0.70 HDAC8 (0.44) MAPK10MAPK9HDAC8MAPKAPK2KEAP1
SCHEMBL18433062 0.70 MAPK10 (0.59) MAPK10MAPK9OPRD1TUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF SU ZHOU JING HONG BIOTECH CO., LTD. (CN) 2013-06-20 — — US disclosed
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF SU ZHOU JING HONG BIOTECH CO., LTD. (CN) 2013-06-20 — — US disclosed
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF SU ZHOU JING HONG BIOTECH CO., LTD. (CN) 2013-06-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF CHRNA10, ATXN10, SCN10A MAPK10 61/4885MAPK9 1943/4885HDAC8 513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback